USHER SYNDROME COALITION
Usher Syndrome Coalition |usher-syndrome.org | Westford, MA | 800.946.9203 Mission The Usher Syndrome Coalition’s mission is to raise...
top of page
Search
- Jan 31, 2022
ProQR seeking Clinical Trial Participants
Usher Syndrome Coalition announces partnership with ProQR to support clinical trial enrollment for a potential therapy for USH2A.
- Dec 21, 2021
First patients dosed in phase 2/3 gene therapy trial for retinitis pigmentosa
The first patients have been dosed in the phase 2/3 Sirius and Celeste clinical trials investigating QR-421a in patients with USH2A.
- May 24, 2021
Clinical Trial News: Positive results in Usher syndrome and RP clinical study
ProQR news – Positive results achieved in our ongoing Usher syndrome and retinitis pigmentosa research.
- Jul 9, 2020
A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome
Lucy S. French, Carla B. Mellough, Fred K. Chen, and Livia S. Carvalho | Frontiers Cell. Neuroscience | 09 July 2020 | Sec. Cellular...
- Dec 31, 2019
USH2A Gene in Retinitis Pigmentosa: A Tale of Three Patients
By Patricia C Sanchez Diaz, DVM, PhD, FAAO Purpose This report aims to illustrate the impact of genetic testing in the diagnosis and...
- Dec 15, 2018
Retinitis Pigmentosa and Allied Disorders
From such work, a “multiprotein scaffold complex” model has been proposed for harmonin, whirlin, and sans.
- Apr 22, 2016
Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa
Targeted next-generation sequencing (NGS) has been demonstrated to be an effective strategy for the detection of mutations in RP.
All Posts
bottom of page